Business Card for James Shaw:


Lead, Patient-Reported Outcomes Assessment ...
 New York, NY area
Email Avail: 3 Day Free Trial


345 Park Ave
New York, NY 10154
Tel: (212) 546-4000

Last updated on 2018-01-18

About James Shaw:

James Shaw works as an Lead, Patient-Reported Outcomes Assessment ... for Bristol-Myers Squibb at New York, NY. The company's webpage is http://www.bms.com. For email, phone number and executive profiles for Lead, Patient-Reported Outcomes Assessment ... and other executives of Bristol-Myers Squibb at New York, NY, check Bristol-Myers Squibb at Joesdata.com. Not the James Shaw you are looking for? Do a quick search in our website and find other people named James Shaw.
James Shaw's Work History:
No information available..

James Shaw's Education:
No information available..

James Shaw's Co-workers:
As of January 25, 2021, James Shaw has 1438 co-workers under the company name Bristol-Myers Squibb at Joesdata.com.

About Bristol-Myers Squibb:

Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Its products are sold worldwide to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. It manufactures products in the United States of America, Puerto Rico and in six foreign countries. The Company launched a subcutaneous formulation of ORENCIA (abatacept) in the United States of America, NULOJIX (belatacept) in the United States of America and the European Union for the prevention of organ rejection in adult patients receiving a kidney transplant. In September 2011, it acquired the Amira Pharmaceuticals, Inc. (Amira)....... (Source: SEC reports)

Company News:
2018-09-12 17:31:09
Bristol-Myers Squibb Announces Dividend
2018-09-06 18:54:14
Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
2018-09-06 17:48:56
Bristol-Myers Squibb to Announce Results for Third Quarter 2018 on October 25
2018-09-06 17:30:46
Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
2018-09-06 17:30:37
Bristol-Myers Squibb to Announce Results for Third Quarter 2018 on October 25
2018-09-05 18:07:03
Bristol-Myers Squibb Kicks Off Coast 2 Coast 4 Cancer Ride to Fundraise for the V Foundation for Cancer Research
2018-09-05 17:30:30
Bristol-Myers Squibb Kicks Off Coast 2 Coast 4 Cancer Ride to Fundraise for the V Foundation for Cancer Research
2018-08-30 19:18:40
U.S. Food and Drug Administration Accepts Bristol-Myers Squibbs Application for Sprycel (dasatinib) in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2018-08-30 17:30:50
U.S. Food and Drug Administration Accepts Bristol-Myers Squibbs Application for Sprycel (dasatinib) in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
2018-08-28 17:31:03
Bristol-Myers Squibb Appoints Christopher Boerner Executive Vice President and Chief Commercial Officer

People in the same industry: